Vol 79, No 1 (2008)

open access

Page views 2312
Article views/downloads 3417
Get Citation

Connect on Social Media

Connect on Social Media

Metformin therapy in polycystic ovary syndrome

Artur J. Jakimiuk
Ginekol Pol 2008;79(1).


Abstract Polycystic ovarian syndrom (PCOS) affects 5% to 10% of women of reproductive age, and is the most common reason of anovulation in infertile women. It is multi-symptom disease. A drug which is used to induce ovulation in women with PCOS is clomiphene citrate. After clomiphene treatment, ovulation is achieved in 56%-73% of women. The rest of them has different level of opportunity to therapy. Clomiphene does not have influence on elementary factor in PCOS which seems to be opportunity to insulin. The drug which can have positive effect is metformin, derivative from biguanid. Its influence on percent of ovulation, pregnancy and live births was evaluated based on randomized trials. Many trials have reserched this so far, but their results are divergent. In this article, we are aiming to systemize results of randomized trials concerning the role of metformin in PCOS therapy.

Article available in PDF format

View PDF Download PDF file